ADPKD Guide
Readable, evidence-first ADPKD treatment, symptoms, diet, trials, and research updates for patients, families, and clinicians.
Last sweep: Jun 1, 2026
What’s New Methodology References Support GitHub
Ask ADPKD Patient Guide Treatment Slow Progression Trials Cure
More
What’s New Newly Diagnosed Tolvaptan Lifestyle Diet Symptoms Clinicians Methodology References Support
ADPKD Patient Guide Patient reading mode

ADPKD — what helps, what is promising, and what is not worth your energy

Evidence tiered honestly. No miracle framing. Updated from peer-reviewed sources.

Last reviewed: July 23, 2026

Evidence at a glance — proven, promising, not proven

Colour-coded so you can see at a glance how strong the evidence is.

Proven / guideline-supported Proven

  • Tolvaptan Proven
  • Blood pressure control Proven
  • Low sodium intake Proven

Promising — human signal, not yet approved Promising

  • Dapagliflozin add-on to tolvaptan Promising
  • SGLT2 inhibitors in non-diabetic ADPKD Promising

Encouraging early data — not yet in clinical guidelines. Do not start without your nephrologist's input.

Not proven — do not rely on these Not proven

  • Any claimed human cure Not proven
  • GLPG2737 (CFTR inhibitor) Not proven
  • Metformin (non-diabetes ADPKD) Not proven

What to do right now — regardless of your stage

  1. Get your blood pressure to target.

    KDIGO 2025 target: below 130/80 mmHg. Home monitoring twice daily is more useful than occasional clinic readings. First-line: ACE inhibitor or ARB (lisinopril, losartan).

  2. Cut sodium to below 2 g/day.

    Processed foods are the main culprit, not the salt shaker. This amplifies the effect of your blood pressure medication and reduces kidney strain.

  3. Know your Mayo Classification.

    Ask your nephrologist. Class 1A–B is lower risk; 1C–E is higher risk and determines tolvaptan eligibility and imaging frequency.

  4. Get your eGFR trend, not just a snapshot.

    A single eGFR reading tells you less than the direction of change over 2–3 years. A declining trend matters more than the absolute value.

Common misconceptions — cleared up quickly

  • "Drinking more water slows my ADPKD." A 3-year RCT found no benefit from prescribed high water intake on kidney growth. Stay hydrated normally.
  • "I feel fine so my kidneys must be fine." Symptoms do not reliably track with progression speed. eGFR trend and kidney volume are better indicators.
  • "Supplements help." No supplement has passed a controlled ADPKD trial. This includes curcumin, resveratrol, green tea, and herbal remedies.
  • "There is a cure coming soon." Gene therapy is in early Phase 2 trials — not approved, not near-term for most. Decades is a more realistic timeframe.
  • "Tolvaptan is only for severe cases." Tolvaptan is for rapid progressors (Mayo 1C+), not necessarily those with worst current function. It is used earlier, not later.
  • "My kidneys will fail quickly." Most people with ADPKD live decades with preserved function, especially when blood pressure and monitoring are managed well.

Find an ADPKD specialist near you

Not all nephrologists have ADPKD expertise. Look for specialists who mention polycystic kidney disease, PKD, or ADPKD. University hospital nephrology departments often have dedicated PKD clinics.

Search Google for ADPKD specialist

Opens Apple Maps on iPhone, Google Maps on Android or desktop. Search "PKD clinic" or "polycystic kidney disease specialist" for best results.